Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes CLINICAL SCIENCES Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes Johanna M. Seddon, MD, ScM; Robyn Reynolds, MPH; Yi Yu, PhD; Bernard Rosner, PhD Importance: Risk score models predicting the progres- tion cohort comprised 980 individuals with no, early, or sion of age-related macular degeneration (AMD) to its ad- intermediate AMD in at least one eye at baseline, of whom vanced forms may be useful for targeting high-risk indi- 294 progressed to advanced stages of geographic atro- viduals for lifestyle changes that reduce risk for AMD phy or neovascular disease. progression, helping with differential diagnosis of AMD and its subtypes, identifying high-risk subjects for participa- Main Outcome Measure: Progression to advanced tion in clinical trials, and selecting appropriate therapies. AMD. Objective: To develop and validate a predictive model Results: For the model with all nongenetic and genetic for progression to advanced stages of AMD in 2 inde- factors, the respective C statistics for progression to ad- pendent cohorts. vanced AMD in the derivation and validation samples were 0.858 and 0.750 at 5 years and 0.884 and 0.809 at 10 years, Design: Participants in a validation cohort and an in- and models also discriminated risk for http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Loading next page...
 
/lp/american-medical-association/validation-of-a-prediction-algorithm-for-progression-to-advanced-HD6gPNYR8s
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2013.2578
pmid
23411794
Publisher site
See Article on Publisher Site

Abstract

CLINICAL SCIENCES Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes Johanna M. Seddon, MD, ScM; Robyn Reynolds, MPH; Yi Yu, PhD; Bernard Rosner, PhD Importance: Risk score models predicting the progres- tion cohort comprised 980 individuals with no, early, or sion of age-related macular degeneration (AMD) to its ad- intermediate AMD in at least one eye at baseline, of whom vanced forms may be useful for targeting high-risk indi- 294 progressed to advanced stages of geographic atro- viduals for lifestyle changes that reduce risk for AMD phy or neovascular disease. progression, helping with differential diagnosis of AMD and its subtypes, identifying high-risk subjects for participa- Main Outcome Measure: Progression to advanced tion in clinical trials, and selecting appropriate therapies. AMD. Objective: To develop and validate a predictive model Results: For the model with all nongenetic and genetic for progression to advanced stages of AMD in 2 inde- factors, the respective C statistics for progression to ad- pendent cohorts. vanced AMD in the derivation and validation samples were 0.858 and 0.750 at 5 years and 0.884 and 0.809 at 10 years, Design: Participants in a validation cohort and an in- and models also discriminated risk for

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Apr 1, 2013

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month